These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 23174013

  • 1. Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.
    Wang Q, Li P, Li A, Jiang W, Wang H, Wang J, Xie K.
    J Exp Clin Cancer Res; 2012 Nov 22; 31(1):97. PubMed ID: 23174013
    [Abstract] [Full Text] [Related]

  • 2. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A, Izadpanahi M, Arab A, Zare-Mirzaei A, Minaeian S, Rostami A, Mohsenian A.
    Clin Neurol Neurosurg; 2020 Mar 22; 190():105652. PubMed ID: 31896490
    [Abstract] [Full Text] [Related]

  • 3. Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma.
    Tang H, Liu Q, Liu X, Ye F, Xie X, Xie X, Wu M.
    J Cancer Res Ther; 2015 Mar 22; 11(3):630-4. PubMed ID: 26458593
    [Abstract] [Full Text] [Related]

  • 4. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ, Zhang MY, Deng ML, Weng NQ, Wang HY, Wu SX.
    PLoS One; 2017 Mar 22; 12(9):e0184969. PubMed ID: 28931080
    [Abstract] [Full Text] [Related]

  • 5. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 6. Plasma miR-454-3p as a potential prognostic indicator in human glioma.
    Shao N, Wang L, Xue L, Wang R, Lan Q.
    Neurol Sci; 2015 Feb 30; 36(2):309-13. PubMed ID: 25190548
    [Abstract] [Full Text] [Related]

  • 7. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y, Alivand M, Mollanoori H.
    Comput Biol Chem; 2021 Jun 30; 92():107458. PubMed ID: 33761401
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 30; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 9. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H, Wang J, Wang Z, Ruan C, Wang L, Guo H.
    Cancer Biomark; 2019 Jan 30; 24(1):43-49. PubMed ID: 30530966
    [Abstract] [Full Text] [Related]

  • 10. Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.
    Herman A, Gruden K, Blejec A, Podpečan V, Motaln H, Rožman P, Hren M, Zupančič K, Veber M, Verbovšek U, Lah Turnšek T, Porčnik A, Koršič M, Knežević M, Jeras M.
    PLoS One; 2015 Jan 30; 10(5):e0125791. PubMed ID: 25950799
    [Abstract] [Full Text] [Related]

  • 11. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.
    Manterola L, Guruceaga E, Gállego Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V, Samprón N, Barrena C, Ruiz I, Agirre A, Ayuso A, Rodríguez J, González A, Xipell E, Matheu A, López de Munain A, Tuñón T, Zazpe I, García-Foncillas J, Paris S, Delattre JY, Alonso MM.
    Neuro Oncol; 2014 Apr 30; 16(4):520-7. PubMed ID: 24435880
    [Abstract] [Full Text] [Related]

  • 12. Clinical impact of circulating oncogenic MiRNA-221 and MiRNA-222 in glioblastoma multiform.
    Swellam M, Ezz El Arab L, Al-Posttany AS, B Said S.
    J Neurooncol; 2019 Sep 30; 144(3):545-551. PubMed ID: 31422498
    [Abstract] [Full Text] [Related]

  • 13. Deep Sequencing of Small RNAs from Neurosurgical Extracellular Vesicles Substantiates miR-486-3p as a Circulating Biomarker that Distinguishes Glioblastoma from Lower-Grade Astrocytoma Patients.
    Hallal S, Ebrahim Khani S, Wei H, Lee MYT, Sim HW, Sy J, Shivalingam B, Buckland ME, Alexander-Kaufman KL.
    Int J Mol Sci; 2020 Jul 13; 21(14):. PubMed ID: 32668808
    [Abstract] [Full Text] [Related]

  • 14. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
    Wu J, Li L, Jiang C.
    Mol Neurobiol; 2015 Dec 13; 52(3):1540-1546. PubMed ID: 25367878
    [Abstract] [Full Text] [Related]

  • 15. miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients.
    Dong L, Li Y, Han C, Wang X, She L, Zhang H.
    Int J Oncol; 2014 Aug 13; 45(2):746-56. PubMed ID: 24858071
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ, Sun W, Wang Y, Li D, Hu AM.
    Eur Rev Med Pharmacol Sci; 2019 Jan 13; 23(1):271-276. PubMed ID: 30657585
    [Abstract] [Full Text] [Related]

  • 17. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.
    Chen J, Yang L, Wang X.
    Cancer Biomark; 2017 Dec 06; 20(4):521-526. PubMed ID: 28946553
    [Abstract] [Full Text] [Related]

  • 18. Serum expression level of miR-504 can differentiate between glioblastoma multiforme and solitary brain metastasis of non-small cell lung carcinoma.
    Jin Z, Jin RH, Ma C, Li HS, Xu HY.
    J BUON; 2017 Dec 06; 22(2):474-480. PubMed ID: 28534372
    [Abstract] [Full Text] [Related]

  • 19. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R, Wang PY, Li XY, Chen JX, Li Y, Zhang XZ, Zhang CG, Jiang T, Li WB, Ding W, Cheng SJ.
    Oncotarget; 2015 Sep 29; 6(29):26971-81. PubMed ID: 26284486
    [Abstract] [Full Text] [Related]

  • 20. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma.
    Ohno M, Matsuzaki J, Kawauchi J, Aoki Y, Miura J, Takizawa S, Kato K, Sakamoto H, Matsushita Y, Takahashi M, Miyakita Y, Ichimura K, Narita Y, Ochiya T.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1916953. PubMed ID: 31808923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.